Chemed (CHE) Accounts Payables (2009 - 2026)

Chemed (CHE) has reported Accounts Payables for 18 consecutive years, with $65.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Accounts Payables rose 37.75% year-over-year to $65.7 million; the TTM figure through Mar 2026 stood at $65.7 million (up 37.75% YoY), while the FY2025 annual figure was $64.5 million, up 46.01% from the prior year.
• Accounts Payables came in at $65.7 million for Q1 2026 at Chemed, up from $64.5 million in the prior quarter.
• The five-year high for Accounts Payables was $77.2 million in Q3 2022, with the low at $40.3 million in Q1 2023.
• Average Accounts Payables over 5 years is $54.4 million, with a median of $50.9 million recorded in 2025.
• The largest YoY upside for Accounts Payables was 52.88% in 2023 against a maximum downside of 44.5% in 2023.
• Year by year, Accounts Payables stood at $41.9 million in 2022, then soared by 52.88% to $64.0 million in 2023, then sank by 31.06% to $44.1 million in 2024, then soared by 46.01% to $64.5 million in 2025, then climbed by 1.92% to $65.7 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $65.7 million, $64.5 million, and $48.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.